Goldman Sachs’s Celularity CELU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,625
| Closed | -$72.6K | – | 4754 |
|
|
2023
Q2 | $72.6K | Buy |
13,625
+10,299
| +310% | +$54.9K | ﹤0.01% | 4619 |
|
|
2023
Q1 | $20.6K | Sell |
3,326
-1,804
| -35% | -$11.2K | ﹤0.01% | 4879 |
|
|
2022
Q4 | $66.2K | Buy |
5,130
+2,193
| +75% | +$28.3K | ﹤0.01% | 4755 |
|
|
2022
Q3 | $68K | Buy |
+2,937
| New | +$68K | ﹤0.01% | 4996 |
|
|
2022
Q2 | – | Sell |
-2,079
| Closed | -$181K | – | 5706 |
|
|
2022
Q1 | $181K | Buy |
+2,079
| New | +$181K | ﹤0.01% | 5132 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$1.01M | – | 5369 |
|
|
2021
Q1 | $1.01M | Buy |
10,000
+3,000
| +43% | +$302K | ﹤0.01% | 3898 |
|
|
2020
Q4 | $770K | Buy |
7,000
+2,000
| +40% | +$220K | ﹤0.01% | 3599 |
|
|
2020
Q3 | $525K | Buy |
+5,000
| New | +$525K | ﹤0.01% | 3645 |
|